These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7214822)

  • 21. [Treatment of metastatic malignant melanoma localized to an extremity].
    Jacobsen KD; Tausjø J; Hager B; Gundersen S
    Tidsskr Nor Laegeforen; 2010 Jan; 130(1):21-4. PubMed ID: 20094118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dimethyl triazeno imidazole carboxamide and combination therapy for melanoma. IV. Late results after complete response to chemotherapy (Central Oncology Group protocols 7130, 7131, and 7131A).
    Hill GJ; Krementz ET; Hill HZ
    Cancer; 1984 Mar; 53(6):1299-305. PubMed ID: 6362841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of grade III and IV astrocytoma with dimethyl triazeno imidazole carboxamide (DTIC, NSC-45388) alone and in combination with CCNU (NSC-79037) or methyl CCNU (MeCCNU, NSC-95441).
    Taylor SG; Nelson L; Baxter D; Rosenbaum C; Sponzo RW; Cunningham TJ; Olson KB; Horton J
    Cancer; 1975 Oct; 36(4):1269-76. PubMed ID: 169984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-response relationship to dacarbazine demonstrated in a patient with malignant melanoma.
    Hoelzer KL; Harrison BR; Luedke DW; Mahanta B
    Cancer Treat Rep; 1986 Oct; 70(10):1211-2. PubMed ID: 3756941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The influence of surgical procedure and the effect of chemotherapy on nodal and distant metastases of human malignant melanomas that have been grafted into nude mice.
    Oguni A; Umeda M; Shigeta T; Takahashi H; Komori T
    Int J Oral Maxillofac Surg; 2010 Jan; 39(1):42-9. PubMed ID: 19962277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoimmunotherapy of advanced malignant melanoma: sequential administration of subcutaneous interleukin-2 and interferon-alpha after intravenous dacarbazine and carboplatin or intravenous dacarbazine, cisplatin, carmustine and tamoxifen.
    Atzpodien J; Lopez Hänninen E; Kirchner H; Franzke A; Körfer A; Volkenandt M; Duensing S; Schomburg A; Chaitchik S; Poliwoda H
    Eur J Cancer; 1995 Jun; 31A(6):876-81. PubMed ID: 7646914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase II study of high-dose hydroxyurea and dacarbazine (DTIC) in the treatment of metastatic malignant melanoma.
    Philip PA; Carmichael J; Tonkin K; Ganesan TA; Harris AL
    Eur J Cancer; 1994; 30A(7):1027-9. PubMed ID: 7946568
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) Surgical Adjuvant Study COG PROTOCOL 7040.
    Hill GJ; Moss SE; Golomb FM; Grage TB; Fletcher WS; Minton JP; Krementz ET
    Cancer; 1981 Jun; 47(11):2556-62. PubMed ID: 7020916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine (NSC-67574) in the treatment of metastatic malignant melanoma.
    Bellett RE; Mastrangelo MJ; Laucius JF; Bodurtha AJ
    Cancer Treat Rep; 1976 May; 60(5):595-600. PubMed ID: 791478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized phase III study of temozolomide versus dacarbazine in the treatment of patients with advanced metastatic malignant melanoma.
    Middleton MR; Grob JJ; Aaronson N; Fierlbeck G; Tilgen W; Seiter S; Gore M; Aamdal S; Cebon J; Coates A; Dreno B; Henz M; Schadendorf D; Kapp A; Weiss J; Fraass U; Statkevich P; Muller M; Thatcher N
    J Clin Oncol; 2000 Jan; 18(1):158-66. PubMed ID: 10623706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of metastatic malignant melanoma with a combination of 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388), cyclophosphamide (NSC-26271), and vincristine (NSC-67574).
    Gardere S; Hussain S; Cowan DH
    Cancer Chemother Rep; 1972 Jun; 56(3):357-61. PubMed ID: 19051495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation in combination with intra-arterial infusion therapy with dacarbazine for metastatic malignant melanoma localized to a lower extremity.
    Gundersen S; Hager B; Tausjø J
    Cancer Treat Rep; 1986 Aug; 70(8):1015-7. PubMed ID: 3731146
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases.
    Can Med Assoc J; 1983 Apr; 128(8):929-33. PubMed ID: 6339024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental dacarbazine antitumor activity and skin toxicity in relation to light exposure and pharmacologic antidotes.
    Dorr RT; Alberts DS; Einspahr J; Mason-Liddil N; Soble M
    Cancer Treat Rep; 1987 Mar; 71(3):267-72. PubMed ID: 3815394
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results with methyl-CCNU and DTIC in metastatic melanoma.
    Costanza ME; Nathanson L; Schoenfeld D; Wolter J; Colsky J; Regelson W; Cunningham T; Sedransk N
    Cancer; 1977 Sep; 40(3):1010-5. PubMed ID: 332319
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacillus Calmette-Guérin immunotherapy in combination with DTIC (NSC-45388) for the treatment of malignant melanoma.
    Gutterman JU; Mavligit GM; Reed R; Burgess MA; Gottlieb J; Hersh EM
    Cancer Treat Rep; 1976 Feb; 60(2):177-82. PubMed ID: 769970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sequential administration of varying doses of dacarbazine and fotemustine in advanced malignant melanoma.
    Lee SM; Margison GP; Woodcock AA; Thatcher N
    Br J Cancer; 1993 Jun; 67(6):1356-60. PubMed ID: 8512821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
    McKelvey EM; Luce JK; Talley RW; Hersh EM; Hewlett JS; Moon TE
    Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.
    Bajetta E; Di Leo A; Zampino MG; Sertoli MR; Comella G; Barduagni M; Giannotti B; Queirolo P; Tribbia G; Bernengo MG
    J Clin Oncol; 1994 Apr; 12(4):806-11. PubMed ID: 8151323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065).
    Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC
    Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.